DepoMed, Inc. (NASDAQ: DEPO) reported Q1 EPS of ($0.10), $0.04 worse than the analyst estimate of ($0.06). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Earnings Guidance